NASDAQ:INM

Inmed Pharmaceuticals Stock Forecast

etoro logo Buy INM
*Your capital is at risk
$1.51
+0 (+0%)
At Close: Jun 15, 2026
AI Analysis AI Analysis of INM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add INM to Watchlist?
Some Reasons Why To Add INM:
  • Beat earnings estimates in all of the last 4 quarters
  • Consistently positive technical signals over the last month
  • Highly efficient cash conversion (100% FCF/OCF ratio)
PDF

Red day on Monday for Inmed Pharmaceuticals Inc. stock after losing 0%
(Updated on Jun 15, 2026)

Buy or Hold candidate since May 20, 2026 Loss -6.21%

No changes to the price of Inmed Pharmaceuticals Inc. stock on the last trading day (Monday, 15th Jun 2026). During the last trading day the stock fluctuated 1.34% from a day low at $1.49 to a day high of $1.51. The price has fallen in 6 of the last 10 days and is down by -3.21% for this period.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 105.76% during the next 3 months and, with a 90% probability hold a price between $1.99 and $4.09 at the end of this 3-month period.

INM Signals & Forecast

The Inmed Pharmaceuticals Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.54. On a fall, the stock will find some support from the long-term average at approximately $1.18. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, May 21, 2026, and so far it has fallen -12.72%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Inmed Pharmaceuticals Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0200 between high and low, or 1.34%. For the last week the stock has had daily average volatility of 4.51%.

Our recommended stop-loss: $1.43 (-5.38%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 16 days ago.)

Trading Expectations (INM) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Inmed Pharmaceuticals Inc. to open at $1.50, and during the day (based on 14 day Average True Range), to move between $1.45 and $1.57, which gives a possible trading interval of +/-$0.113 (+/-7.77%) up or down from last closing price. If Inmed Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 7.77% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.60, some $0.0900 (5.96%) from the current price of $1.51, our system finds the risk reward not very attractive.

Is Inmed Pharmaceuticals Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Inmed Pharmaceuticals Inc. stock to perform well in the short-term.

Current score: 1.319 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 16, 2026 - $1.50 ( 0.442%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

INM Performance

Trading levels for INM

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.52 0.88%
R2 1.52 0.377%
R1 1.51 0.0645%
Price 1.51
S1 1.50 -0.95%
S2 1.49 -1.26%
S3 1.48 -1.77%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.73 14.57%
R2 1.61 6.62%
R1 1.60 5.96%
Price 1.51
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Inmed Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Inmed Pharmaceuticals Inc. is INM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Inmed Pharmaceuticals Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Inmed Pharmaceuticals Inc. stock to perform well in the short-term.

How to buy Inmed Pharmaceuticals Inc. Stock?
Inmed Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inmed Pharmaceuticals Inc. Stock.

What's the current price of Inmed Pharmaceuticals Inc. Stock?
As of the end of day on the Jun 15, 2026, the price of an Inmed Pharmaceuticals Inc. (INM) share was $1.51.

What is the 52-week high and low for Inmed Pharmaceuticals Inc. Stock?
The 52-week high for Inmed Pharmaceuticals Inc. Stock is $5.50 and the 52-week low is $0.575.

What is the market capitalization of Inmed Pharmaceuticals Inc. Stock?
As of the Jun 15, 2026, the market capitalization of Inmed Pharmaceuticals Inc. is 2.733M.

When is the next earnings date for Inmed Pharmaceuticals Inc.?
The upcoming earnings date for Inmed Pharmaceuticals Inc. is Sep 18, 2026.
Click to get the best stock tips daily for free!
ABOUT INMED PHARMACEUTICALS INC.
Inmed Pharmaceuticals
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it en...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.84
4.82% Jun 11
EAT
$140.46
11.23% Jun 05
TPR
$140.47
7.49% Jun 04
LITE
$905.00
5.77% Jun 01
W
WCLD
$27.34
12.84% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE